Ipamorelin triggers GH release via ghrelin receptors without increasing cortisol or prolactin. CJC-1295 triggers GH via GHRH receptors.
| Feature / Metric | Ipamorelin | CJC-1295 |
|---|---|---|
| Receptor Pathway | Ghrelin / GHSR-1a | GHRH Receptor |
| Cortisol/Prolactin Elevation | None (Selective) | Minimal |
Access chemical profile, half-life parameters, and U-100 reconstitution calculator.
Access chemical profile, half-life parameters, and U-100 reconstitution calculator.
Ipamorelin triggers GH release via ghrelin receptors without increasing cortisol or prolactin. CJC-1295 triggers GH via GHRH receptors. In preclinical and clinical research trials, comparing receptor affinity, half-life clearance, and synthesis purity standards is critical for determining appropriate research protocols.
In scientific literature, certain peptide pairs (such as BPC-157 + TB-500, or CJC-1295 + Ipamorelin) exhibit complementary signaling pathways and are frequently studied together in stack protocols.
